Akreos® Posterior Chamber Intraocular Lens (IOL)

FDA Premarket Approval P060022 S030

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceAkreos® Posterior Chamber Intraocular Lens (IOL)
Generic NameIntraocular Lens
ApplicantBausch & Lomb, Inc.50 Technology Driveirvine, CA 92618 PMA NumberP060022 Supplement NumberS030 Date Received08/16/2022 Decision Date09/20/2022 Product Code HQL  Advisory Committee Ophthalmic Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
Date Received2022-08-16
Decision Date2022-09-20
PMAP060022
SupplementS030
Product CodeHQL 
Advisory CommitteeOphthalmic
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination ProductNo
Applicant AddressBausch & Lomb, Inc.
50 Technology Drive
irvine, CA 92618 PMA NumberP060022 Supplement NumberS030 Date Received08/16/2022 Decision Date09/20/2022 Product Code HQL  Advisory Committee Ophthalmic Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No Combination ProductNo Approval Order Statement  
to Add The Bubble Leak Test To Incoming Inspection As An Alternate Test Method

Supplemental Filings

Supplement NumberDateSupplement Type
P060022Original Filing
S030 2022-08-16 30-day Notice
S029 2021-12-22 30-day Notice
S028 2020-12-04 30-day Notice
S027
S026
S025 2019-12-23 30-day Notice
S024 2018-07-10 30-day Notice
S023 2016-06-03 30-day Notice
S022 2015-09-11 135 Review Track For 30-day Notice
S021 2015-02-18 30-day Notice
S020 2014-12-08 Real-time Process
S019 2014-05-15 30-day Notice
S018
S017 2013-06-10 30-day Notice
S016 2013-04-15 Real-time Process
S015 2013-02-22 30-day Notice
S014 2012-08-20 30-day Notice
S013 2012-03-20 Real-time Process
S012 2011-06-21 Normal 180 Day Track
S011 2011-05-09 30-day Notice
S010 2011-02-16 Normal 180 Day Track No User Fee
S009 2011-03-18 30-day Notice
S008 2011-03-18 135 Review Track For 30-day Notice
S007 2010-04-30 30-day Notice
S006 2010-01-29 Real-time Process
S005 2009-08-25 30-day Notice
S004 2009-03-06 30-day Notice
S003
S002 2008-10-24 Real-time Process
S001 2008-10-20 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.